Retinal Drugs Market Research Report Information By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Indication (Macular Degeneration, Diabetic Eye Disease, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL

6.1. Overview

6.2. Hospital pharmacy

6.3. Retail pharmacy

6.4. Online Pharmacy

7. GLOBAL RETINAL DRUGS MARKET, BY INDICATION

7.1. Overview

7.2. Macular degeneration

7.3. Diabetic eye disease

7.4. Others

8. GLOBAL RETINAL DRUGS MARKET, BY REGION

8.1. Overview

8.2. North America

8.2.1. U.S.

8.2.2. Canada

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. U.K

8.3.4. Italy

8.3.5. Spain

8.3.6. Rest of Europe

8.4. Asia-Pacific

8.4.1. China

8.4.2. India

8.4.3. Japan

8.4.4. South Korea

8.4.5. Australia

8.4.6. Rest of Asia-Pacific

8.5. Rest of the World

8.5.1. Middle East

8.5.2. Africa

8.5.3. Latin America

9. COMPETITIVE LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Retinal Drugs Market,

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Retinal Drugs Market,

9.7. Key developments and Growth Strategies

9.7.1. New Distribution Channel Launch/Indication Deployment

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Bayer AG

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Product Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. ALCON INC.

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Product Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Alimera Sciences Inc.

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Product Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Bausch Health Co Inc.

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Product Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Bristol Myers Squibb Co.

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Product Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. F. Hoffmann La Roche Ltd.

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Product Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Kubota Corp.

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Product Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. MeiraGTx Holdings Plc

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Product Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Novartis AG

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Product Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL RETINAL DRUGS MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL RETINAL DRUGS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 5 NORTH AMERICA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA RETINAL DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 8 U.S. RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 9 U.S. RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 10 CANADA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 11 CANADA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 12 EUROPE RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 13 EUROPE RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 14 EUROPE RETINAL DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 15 GERMANY RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 16 GERMANY RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 17 FRANCE RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 18 FRANCE RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 19 ITALY RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 20 ITALY RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 21 SPAIN RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 22 SPAIN RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 23 U.K RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 24 U.K RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 25 REST OF EUROPE RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 26 REST OF EUROPE RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 27 ASIA PACIFIC RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 28 ASIA PACIFIC RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 29 ASIA PACIFIC RETINAL DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 30 JAPAN RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 31 JAPAN RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 32 CHINA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 33 CHINA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 34 INDIA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 35 INDIA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 36 AUSTRALIA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 37 AUSTRALIA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 38 SOUTH KOREA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 39 SOUTH KOREA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 40 REST OF ASIA-PACIFIC RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 41 REST OF ASIA-PACIFIC RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 42 REST OF WORLD RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 43 REST OF WORLD RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 44 REST OF WORLD RETINAL DRUGS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 45 MIDDLE EAST RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 46 MIDDLE EAST RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 47 AFRICA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 48 AFRICA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

TABLE 49 LATIN AMERICA RETINAL DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)

TABLE 50 LATIN AMERICA RETINAL DRUGS MARKET, BY INDICATION, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL RETINAL DRUGS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL RETINAL DRUGS MARKET

FIGURE 4 GLOBAL RETINAL DRUGS MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022

FIGURE 5 GLOBAL RETINAL DRUGS MARKET, SHARE (%), BY INDICATION, 2022

FIGURE 6 GLOBAL RETINAL DRUGS MARKET, SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: RETINAL DRUGS MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 EUROPE: RETINAL DRUGS MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 ASIA-PACIFIC: RETINAL DRUGS MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 REST OF THE WORLD: RETINAL DRUGS MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 GLOBAL RETINAL DRUGS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 12 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 BAYER AG: SWOT ANALYSIS

FIGURE 14 ALCON INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ALCON INC.: SWOT ANALYSIS

FIGURE 16 ALIMERA SCIENCES INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 ALIMERA SCIENCES INC.: SWOT ANALYSIS

FIGURE 18 BAUSCH HEALTH CO INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 BAUSCH HEALTH CO INC.: SWOT ANALYSIS

FIGURE 20 BRISTOL MYERS SQUIBB CO..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 BRISTOL MYERS SQUIBB CO..: SWOT ANALYSIS

FIGURE 22 F. HOFFMANN LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 F. HOFFMANN LA ROCHE LTD.: SWOT ANALYSIS

FIGURE 24 KUBOTA CORP.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 KUBOTA CORP.: SWOT ANALYSIS

FIGURE 26 MEIRAGTX HOLDINGS PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 MEIRAGTX HOLDINGS PLC: SWOT ANALYSIS

FIGURE 28 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 NOVARTIS AG: SWOT ANALYSIS